Regarding BIEL's medical devices and their imminent success . . . .
Hey 7Up
I suspect there are very, very few "off-the-wall calls", to be made to BIEL management, in the future, as you suggest may happen.
Existing and prospective Shareholders of BIEL now generally know what the company has and are pleased and more confident than ever before about its amazing progress.
The press release in January about being added to the UK NHS Tariff on April 1 came to pass on schedule and as announced earlier, for all the world to see in the actual Tariff, nothing more to learn about that. >28 Million Brits with chronic pain and there have already been articles in the British media and websites this week on the news.
I do not want to know the current status of any discussions with any parties as to possible commercial relationships in the U.S., period, until those deals are inked and all parties concur on when to release such news and how. Experienced business people know that such announcements contain launch timing and marketing and sales targets and those are never addressed until foundation deals are made.
Every company I have been involved with, or know about, that has gone through an exhausting FDA drug approval or device clearance process, before going to market, and I have been involved in both processes, would see BIEL's journey as amazing! The brilliance of what has happened is that BIEL did not wait for the FDA to give the necessary clearances, foot, knee, back, general to go to market in the U.S. No, they went overseas, did deals in many countries and were added to the UK NHS health insurance coverage tariff on April 1! For what my opinion is worth, I applaud Andrew Whelan and his team at BIEL for this amazing accomplishment.
I was actually asked recently what the word 'now' means.
Now means the following:
1. ActiPatch listed on the UK NHS Tariff, now;
2. ActiPatch Back trial submission, requested by FDA under review, now;
3. Allay trial for dysmenorrhea underway, now;
4. Migraine trial, now;
Etc.
Etc.
So many nows 7Up . . . . too many to list. Bottom line is that wise investors know that BIEL is poised for great success now and it doesn't take a call to the company to know what's going on . . . .anything else is none of my business, at the moment - BIEL has business positions to protect and I am just not entitled to, nor do I want to know what they are . . . . is there anything else of importance to know?
